PMC:3218875 / 31641-31904 JSONTXT

{"project":"testone","denotations":[{"id":"T17355","span":{"begin":43,"end":53},"obj":"Gene_expression"},{"id":"T17354","span":{"begin":31,"end":38},"obj":"Positive_regulation"},{"id":"T17336","span":{"begin":113,"end":120},"obj":"Protein"},{"id":"T17335","span":{"begin":39,"end":42},"obj":"Protein"},{"id":"T17334","span":{"begin":10,"end":17},"obj":"Protein"}],"relations":[{"id":"R11381","pred":"causeOf","subj":"T17334","obj":"T17354"},{"id":"R11382","pred":"themeOf","subj":"T17335","obj":"T17355"},{"id":"R11390","pred":"themeOf","subj":"T17355","obj":"T17354"}],"text":"Moreover, miR-155 was shown to promote TNF production, a key process in the pathogenesis of RA [87]. miR-146 and miR-155 may therefore be important negative regulators of inflammation in RA and their potential for the development of new treatments is substantial."}

{"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T18342","span":{"begin":262,"end":263},"obj":"."},{"id":"T18341","span":{"begin":251,"end":262},"obj":"JJ"},{"id":"T18340","span":{"begin":248,"end":250},"obj":"VBZ"},{"id":"T18339","span":{"begin":237,"end":247},"obj":"NNS"},{"id":"T18338","span":{"begin":233,"end":236},"obj":"JJ"},{"id":"T18337","span":{"begin":230,"end":232},"obj":"IN"},{"id":"T18336","span":{"begin":218,"end":229},"obj":"NN"},{"id":"T18335","span":{"begin":214,"end":217},"obj":"DT"},{"id":"T18334","span":{"begin":210,"end":213},"obj":"IN"},{"id":"T18333","span":{"begin":200,"end":209},"obj":"NN"},{"id":"T18332","span":{"begin":194,"end":199},"obj":"PRP$"},{"id":"T18331","span":{"begin":190,"end":193},"obj":"CC"},{"id":"T18330","span":{"begin":187,"end":189},"obj":"NNP"},{"id":"T18329","span":{"begin":184,"end":186},"obj":"IN"},{"id":"T18328","span":{"begin":171,"end":183},"obj":"NN"},{"id":"T18327","span":{"begin":168,"end":170},"obj":"IN"},{"id":"T18326","span":{"begin":157,"end":167},"obj":"NNS"},{"id":"T18325","span":{"begin":148,"end":156},"obj":"JJ"},{"id":"T18324","span":{"begin":138,"end":147},"obj":"JJ"},{"id":"T18323","span":{"begin":135,"end":137},"obj":"VB"},{"id":"T18322","span":{"begin":125,"end":134},"obj":"RB"},{"id":"T18321","span":{"begin":121,"end":124},"obj":"MD"},{"id":"T18320","span":{"begin":113,"end":120},"obj":"NN"},{"id":"T18319","span":{"begin":109,"end":112},"obj":"CC"},{"id":"T18318","span":{"begin":101,"end":108},"obj":"NN"},{"id":"T18317","span":{"begin":99,"end":100},"obj":"."},{"id":"T18316","span":{"begin":98,"end":99},"obj":"NNP"},{"id":"T18315","span":{"begin":96,"end":98},"obj":"CD"},{"id":"T18314","span":{"begin":95,"end":96},"obj":"NNP"},{"id":"T18313","span":{"begin":92,"end":94},"obj":"NNP"},{"id":"T18312","span":{"begin":89,"end":91},"obj":"IN"},{"id":"T18311","span":{"begin":76,"end":88},"obj":"NN"},{"id":"T18310","span":{"begin":72,"end":75},"obj":"DT"},{"id":"T18309","span":{"begin":69,"end":71},"obj":"IN"},{"id":"T18308","span":{"begin":61,"end":68},"obj":"NN"},{"id":"T18307","span":{"begin":57,"end":60},"obj":"JJ"},{"id":"T18306","span":{"begin":55,"end":56},"obj":"DT"},{"id":"T18305","span":{"begin":53,"end":54},"obj":","},{"id":"T18304","span":{"begin":43,"end":53},"obj":"NN"},{"id":"T18303","span":{"begin":39,"end":42},"obj":"NNP"},{"id":"T18302","span":{"begin":31,"end":38},"obj":"VB"},{"id":"T18301","span":{"begin":28,"end":30},"obj":"TO"},{"id":"T18300","span":{"begin":22,"end":27},"obj":"VBN"},{"id":"T18299","span":{"begin":18,"end":21},"obj":"VBD"},{"id":"T18298","span":{"begin":10,"end":17},"obj":"NN"},{"id":"T18297","span":{"begin":8,"end":9},"obj":","},{"id":"T18296","span":{"begin":0,"end":8},"obj":"RB"}],"relations":[{"id":"R12152","pred":"advmod","subj":"T18296","obj":"T18300"},{"id":"R12153","pred":"punct","subj":"T18297","obj":"T18300"},{"id":"R12154","pred":"nsubjpass","subj":"T18298","obj":"T18300"},{"id":"R12155","pred":"auxpass","subj":"T18299","obj":"T18300"},{"id":"R12156","pred":"ROOT","subj":"T18300","obj":"T18300"},{"id":"R12157","pred":"aux","subj":"T18301","obj":"T18302"},{"id":"R12158","pred":"xcomp","subj":"T18302","obj":"T18300"},{"id":"R12159","pred":"compound","subj":"T18303","obj":"T18304"},{"id":"R12160","pred":"dobj","subj":"T18304","obj":"T18302"},{"id":"R12161","pred":"punct","subj":"T18305","obj":"T18304"},{"id":"R12162","pred":"det","subj":"T18306","obj":"T18308"},{"id":"R12163","pred":"amod","subj":"T18307","obj":"T18308"},{"id":"R12164","pred":"appos","subj":"T18308","obj":"T18304"},{"id":"R12165","pred":"prep","subj":"T18309","obj":"T18308"},{"id":"R12166","pred":"det","subj":"T18310","obj":"T18311"},{"id":"R12167","pred":"pobj","subj":"T18311","obj":"T18309"},{"id":"R12168","pred":"prep","subj":"T18312","obj":"T18311"},{"id":"R12169","pred":"compound","subj":"T18313","obj":"T18314"},{"id":"R12170","pred":"pobj","subj":"T18314","obj":"T18312"},{"id":"R12171","pred":"nummod","subj":"T18315","obj":"T18316"},{"id":"R12172","pred":"appos","subj":"T18316","obj":"T18311"},{"id":"R12173","pred":"punct","subj":"T18317","obj":"T18300"},{"id":"R12174","pred":"nsubj","subj":"T18318","obj":"T18323"},{"id":"R12175","pred":"cc","subj":"T18319","obj":"T18318"},{"id":"R12176","pred":"conj","subj":"T18320","obj":"T18318"},{"id":"R12177","pred":"aux","subj":"T18321","obj":"T18323"},{"id":"R12178","pred":"advmod","subj":"T18322","obj":"T18323"},{"id":"R12179","pred":"ROOT","subj":"T18323","obj":"T18323"},{"id":"R12180","pred":"amod","subj":"T18324","obj":"T18326"},{"id":"R12181","pred":"amod","subj":"T18325","obj":"T18326"},{"id":"R12182","pred":"attr","subj":"T18326","obj":"T18323"},{"id":"R12183","pred":"prep","subj":"T18327","obj":"T18326"},{"id":"R12184","pred":"pobj","subj":"T18328","obj":"T18327"},{"id":"R12185","pred":"prep","subj":"T18329","obj":"T18328"},{"id":"R12186","pred":"pobj","subj":"T18330","obj":"T18329"},{"id":"R12187","pred":"cc","subj":"T18331","obj":"T18323"},{"id":"R12188","pred":"poss","subj":"T18332","obj":"T18333"},{"id":"R12189","pred":"nsubj","subj":"T18333","obj":"T18340"},{"id":"R12190","pred":"prep","subj":"T18334","obj":"T18333"},{"id":"R12191","pred":"det","subj":"T18335","obj":"T18336"},{"id":"R12192","pred":"pobj","subj":"T18336","obj":"T18334"},{"id":"R12193","pred":"prep","subj":"T18337","obj":"T18336"},{"id":"R12194","pred":"amod","subj":"T18338","obj":"T18339"},{"id":"R12195","pred":"pobj","subj":"T18339","obj":"T18337"},{"id":"R12196","pred":"conj","subj":"T18340","obj":"T18323"},{"id":"R12197","pred":"acomp","subj":"T18341","obj":"T18340"},{"id":"R12198","pred":"punct","subj":"T18342","obj":"T18340"}],"text":"Moreover, miR-155 was shown to promote TNF production, a key process in the pathogenesis of RA [87]. miR-146 and miR-155 may therefore be important negative regulators of inflammation in RA and their potential for the development of new treatments is substantial."}

{"project":"DLUT931","denotations":[{"id":"T18587","span":{"begin":31,"end":38},"obj":"Positive_regulation"},{"id":"T18586","span":{"begin":43,"end":53},"obj":"Gene_expression"},{"id":"T18571","span":{"begin":113,"end":120},"obj":"Protein"},{"id":"T18570","span":{"begin":39,"end":42},"obj":"Protein"},{"id":"T18569","span":{"begin":10,"end":17},"obj":"Protein"}],"relations":[{"id":"R12380","pred":"causeOf","subj":"T18569","obj":"T18587"},{"id":"R12381","pred":"themeOf","subj":"T18570","obj":"T18586"},{"id":"R12389","pred":"themeOf","subj":"T18586","obj":"T18587"}],"text":"Moreover, miR-155 was shown to promote TNF production, a key process in the pathogenesis of RA [87]. miR-146 and miR-155 may therefore be important negative regulators of inflammation in RA and their potential for the development of new treatments is substantial."}

{"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T18503","span":{"begin":39,"end":42},"obj":"http://www.uniprot.org/uniprot/P01375"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"Moreover, miR-155 was shown to promote TNF production, a key process in the pathogenesis of RA [87]. miR-146 and miR-155 may therefore be important negative regulators of inflammation in RA and their potential for the development of new treatments is substantial."}

{"project":"bionlp-st-ge-2016-test-proteins","denotations":[{"id":"T17533","span":{"begin":113,"end":120},"obj":"Protein"},{"id":"T17532","span":{"begin":39,"end":42},"obj":"Protein"},{"id":"T17531","span":{"begin":10,"end":17},"obj":"Protein"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"Moreover, miR-155 was shown to promote TNF production, a key process in the pathogenesis of RA [87]. miR-146 and miR-155 may therefore be important negative regulators of inflammation in RA and their potential for the development of new treatments is substantial."}

{"project":"bionlp-st-ge-2016-coref","denotations":[{"id":"T17512","span":{"begin":113,"end":120},"obj":"Antecedent"}],"namespaces":[{"prefix":"_base","uri":"https://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"Moreover, miR-155 was shown to promote TNF production, a key process in the pathogenesis of RA [87]. miR-146 and miR-155 may therefore be important negative regulators of inflammation in RA and their potential for the development of new treatments is substantial."}

{"project":"2_test","denotations":[{"id":"21639951-17463289-4289521","span":{"begin":96,"end":98},"obj":"17463289"}],"text":"Moreover, miR-155 was shown to promote TNF production, a key process in the pathogenesis of RA [87]. miR-146 and miR-155 may therefore be important negative regulators of inflammation in RA and their potential for the development of new treatments is substantial."}

{"project":"pmc-enju-pas","denotations":[{"id":"T17797","span":{"begin":76,"end":88},"obj":"NN"},{"id":"T17796","span":{"begin":72,"end":75},"obj":"DT"},{"id":"T17795","span":{"begin":69,"end":71},"obj":"IN"},{"id":"T17794","span":{"begin":61,"end":68},"obj":"NN"},{"id":"T17793","span":{"begin":57,"end":60},"obj":"JJ"},{"id":"T17792","span":{"begin":55,"end":56},"obj":"DT"},{"id":"T17791","span":{"begin":53,"end":54},"obj":"-COMMA-"},{"id":"T17790","span":{"begin":43,"end":53},"obj":"NN"},{"id":"T17789","span":{"begin":39,"end":42},"obj":"NN"},{"id":"T17788","span":{"begin":31,"end":38},"obj":"VB"},{"id":"T17787","span":{"begin":28,"end":30},"obj":"TO"},{"id":"T17786","span":{"begin":22,"end":27},"obj":"VB"},{"id":"T17785","span":{"begin":18,"end":21},"obj":"VB"},{"id":"T17784","span":{"begin":10,"end":17},"obj":"NN"},{"id":"T17783","span":{"begin":8,"end":9},"obj":"-COMMA-"},{"id":"T17782","span":{"begin":0,"end":8},"obj":"RB"},{"id":"T17826","span":{"begin":230,"end":241},"obj":"JJ"},{"id":"T17825","span":{"begin":228,"end":230},"obj":"VB"},{"id":"T17824","span":{"begin":218,"end":228},"obj":"NN"},{"id":"T17823","span":{"begin":214,"end":217},"obj":"JJ"},{"id":"T17822","span":{"begin":211,"end":213},"obj":"IN"},{"id":"T17821","span":{"begin":200,"end":211},"obj":"NN"},{"id":"T17820","span":{"begin":197,"end":200},"obj":"DT"},{"id":"T17819","span":{"begin":194,"end":197},"obj":"IN"},{"id":"T17818","span":{"begin":184,"end":193},"obj":"NN"},{"id":"T17817","span":{"begin":179,"end":184},"obj":"PRP-DOLLAR-"},{"id":"T17816","span":{"begin":176,"end":179},"obj":"CC"},{"id":"T17815","span":{"begin":174,"end":176},"obj":"NN"},{"id":"T17814","span":{"begin":172,"end":174},"obj":"IN"},{"id":"T17813","span":{"begin":160,"end":172},"obj":"NN"},{"id":"T17812","span":{"begin":158,"end":160},"obj":"IN"},{"id":"T17811","span":{"begin":148,"end":158},"obj":"NN"},{"id":"T17810","span":{"begin":139,"end":147},"obj":"JJ"},{"id":"T17809","span":{"begin":130,"end":139},"obj":"JJ"},{"id":"T17808","span":{"begin":128,"end":130},"obj":"VB"},{"id":"T17807","span":{"begin":119,"end":128},"obj":"RB"},{"id":"T17806","span":{"begin":116,"end":119},"obj":"MD"},{"id":"T17805","span":{"begin":109,"end":116},"obj":"NN"},{"id":"T17804","span":{"begin":106,"end":109},"obj":"CC"},{"id":"T17803","span":{"begin":99,"end":106},"obj":"NN"},{"id":"T17802","span":{"begin":98,"end":99},"obj":"-RRB-"},{"id":"T17801","span":{"begin":96,"end":98},"obj":"CD"},{"id":"T17800","span":{"begin":95,"end":96},"obj":"-LRB-"},{"id":"T17799","span":{"begin":92,"end":94},"obj":"NN"},{"id":"T17798","span":{"begin":89,"end":91},"obj":"IN"}],"relations":[{"id":"R11688","pred":"arg1Of","subj":"T17784","obj":"T17785"},{"id":"R11689","pred":"arg2Of","subj":"T17784","obj":"T17786"},{"id":"R11690","pred":"arg1Of","subj":"T17784","obj":"T17788"},{"id":"R11691","pred":"arg2Of","subj":"T17786","obj":"T17785"},{"id":"R11692","pred":"arg1Of","subj":"T17786","obj":"T17804"},{"id":"R11693","pred":"arg3Of","subj":"T17788","obj":"T17786"},{"id":"R11694","pred":"arg1Of","subj":"T17788","obj":"T17787"},{"id":"R11695","pred":"arg1Of","subj":"T17788","obj":"T17795"},{"id":"R11696","pred":"arg2Of","subj":"T17790","obj":"T17788"},{"id":"R11697","pred":"arg1Of","subj":"T17790","obj":"T17789"},{"id":"R11698","pred":"arg1Of","subj":"T17790","obj":"T17791"},{"id":"R11699","pred":"arg2Of","subj":"T17794","obj":"T17791"},{"id":"R11700","pred":"arg1Of","subj":"T17794","obj":"T17792"},{"id":"R11701","pred":"arg1Of","subj":"T17794","obj":"T17793"},{"id":"R11702","pred":"arg2Of","subj":"T17797","obj":"T17795"},{"id":"R11703","pred":"arg1Of","subj":"T17797","obj":"T17796"},{"id":"R11704","pred":"arg1Of","subj":"T17797","obj":"T17798"},{"id":"R11705","pred":"arg2Of","subj":"T17799","obj":"T17798"},{"id":"R11706","pred":"arg2Of","subj":"T17801","obj":"T17800"},{"id":"R11707","pred":"arg3Of","subj":"T17802","obj":"T17800"},{"id":"R11708","pred":"arg3Of","subj":"T17803","obj":"T17795"},{"id":"R11709","pred":"arg1Of","subj":"T17803","obj":"T17800"},{"id":"R11710","pred":"arg1Of","subj":"T17804","obj":"T17816"},{"id":"R11711","pred":"arg1Of","subj":"T17805","obj":"T17806"},{"id":"R11712","pred":"arg1Of","subj":"T17805","obj":"T17808"},{"id":"R11713","pred":"arg2Of","subj":"T17808","obj":"T17804"},{"id":"R11714","pred":"arg2Of","subj":"T17808","obj":"T17806"},{"id":"R11715","pred":"arg1Of","subj":"T17808","obj":"T17807"},{"id":"R11716","pred":"arg1Of","subj":"T17810","obj":"T17809"},{"id":"R11717","pred":"arg2Of","subj":"T17811","obj":"T17808"},{"id":"R11718","pred":"arg1Of","subj":"T17811","obj":"T17810"},{"id":"R11719","pred":"arg1Of","subj":"T17811","obj":"T17812"},{"id":"R11720","pred":"arg1Of","subj":"T17811","obj":"T17814"},{"id":"R11721","pred":"arg2Of","subj":"T17813","obj":"T17812"},{"id":"R11722","pred":"arg2Of","subj":"T17815","obj":"T17814"},{"id":"R11723","pred":"arg1Of","subj":"T17816","obj":"T17782"},{"id":"R11724","pred":"arg1Of","subj":"T17816","obj":"T17783"},{"id":"R11725","pred":"arg1Of","subj":"T17818","obj":"T17817"},{"id":"R11726","pred":"arg1Of","subj":"T17818","obj":"T17819"},{"id":"R11727","pred":"arg1Of","subj":"T17818","obj":"T17825"},{"id":"R11728","pred":"arg1Of","subj":"T17818","obj":"T17826"},{"id":"R11729","pred":"arg2Of","subj":"T17821","obj":"T17819"},{"id":"R11730","pred":"arg1Of","subj":"T17821","obj":"T17820"},{"id":"R11731","pred":"arg1Of","subj":"T17821","obj":"T17822"},{"id":"R11732","pred":"arg2Of","subj":"T17824","obj":"T17822"},{"id":"R11733","pred":"arg1Of","subj":"T17824","obj":"T17823"},{"id":"R11734","pred":"arg2Of","subj":"T17825","obj":"T17816"},{"id":"R11735","pred":"arg2Of","subj":"T17826","obj":"T17825"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"Moreover, miR-155 was shown to promote TNF production, a key process in the pathogenesis of RA [87]. miR-146 and miR-155 may therefore be important negative regulators of inflammation in RA and their potential for the development of new treatments is substantial."}

{"project":"GO-BP","denotations":[{"id":"T17987","span":{"begin":171,"end":183},"obj":"http://purl.obolibrary.org/obo/GO_0006954"},{"id":"T17984","span":{"begin":218,"end":229},"obj":"http://purl.obolibrary.org/obo/GO_0032502"},{"id":"T17997","span":{"begin":76,"end":88},"obj":"http://purl.obolibrary.org/obo/GO_0009405"},{"id":"T17996","span":{"begin":39,"end":53},"obj":"http://purl.obolibrary.org/obo/GO_0032640"}],"text":"Moreover, miR-155 was shown to promote TNF production, a key process in the pathogenesis of RA [87]. miR-146 and miR-155 may therefore be important negative regulators of inflammation in RA and their potential for the development of new treatments is substantial."}

{"project":"sentences","denotations":[{"id":"T17444","span":{"begin":0,"end":263},"obj":"Sentence"},{"id":"T181","span":{"begin":0,"end":263},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Moreover, miR-155 was shown to promote TNF production, a key process in the pathogenesis of RA [87]. miR-146 and miR-155 may therefore be important negative regulators of inflammation in RA and their potential for the development of new treatments is substantial."}

{"project":"simple1","denotations":[{"id":"T18029","span":{"begin":113,"end":120},"obj":"Protein"},{"id":"T18028","span":{"begin":39,"end":42},"obj":"Protein"},{"id":"T18027","span":{"begin":10,"end":17},"obj":"Protein"}],"text":"Moreover, miR-155 was shown to promote TNF production, a key process in the pathogenesis of RA [87]. miR-146 and miR-155 may therefore be important negative regulators of inflammation in RA and their potential for the development of new treatments is substantial."}

{"project":"BioNLP16_DUT","denotations":[{"id":"T18762","span":{"begin":113,"end":120},"obj":"Protein"},{"id":"T18761","span":{"begin":39,"end":42},"obj":"Protein"},{"id":"T18760","span":{"begin":10,"end":17},"obj":"Protein"},{"id":"T18780","span":{"begin":43,"end":53},"obj":"Gene_expression"},{"id":"T18779","span":{"begin":31,"end":38},"obj":"Positive_regulation"}],"relations":[{"id":"R12440","pred":"themeOf","subj":"T18761","obj":"T18780"},{"id":"R12448","pred":"themeOf","subj":"T18780","obj":"T18779"}],"text":"Moreover, miR-155 was shown to promote TNF production, a key process in the pathogenesis of RA [87]. miR-146 and miR-155 may therefore be important negative regulators of inflammation in RA and their potential for the development of new treatments is substantial."}

{"project":"BioNLP16_Messiy","denotations":[{"id":"T18546","span":{"begin":31,"end":38},"obj":"Positive_regulation"},{"id":"T18545","span":{"begin":43,"end":53},"obj":"Gene_expression"},{"id":"T18529","span":{"begin":113,"end":120},"obj":"Protein"},{"id":"T18528","span":{"begin":39,"end":42},"obj":"Protein"},{"id":"T18527","span":{"begin":10,"end":17},"obj":"Protein"}],"relations":[{"id":"R12364","pred":"themeOf","subj":"T18528","obj":"T18545"},{"id":"R12371","pred":"themeOf","subj":"T18545","obj":"T18546"}],"text":"Moreover, miR-155 was shown to promote TNF production, a key process in the pathogenesis of RA [87]. miR-146 and miR-155 may therefore be important negative regulators of inflammation in RA and their potential for the development of new treatments is substantial."}

{"project":"bionlp-st-ge-2016-test-ihmc","denotations":[{"id":"T18851","span":{"begin":113,"end":120},"obj":"Protein"},{"id":"T18826","span":{"begin":10,"end":17},"obj":"Protein"},{"id":"T18824","span":{"begin":101,"end":108},"obj":"Entity"},{"id":"T18807","span":{"begin":187,"end":189},"obj":"Protein"},{"id":"T18789","span":{"begin":92,"end":94},"obj":"Protein"}],"text":"Moreover, miR-155 was shown to promote TNF production, a key process in the pathogenesis of RA [87]. miR-146 and miR-155 may therefore be important negative regulators of inflammation in RA and their potential for the development of new treatments is substantial."}

{"project":"bionlp-st-ge-2016-test-tees","denotations":[{"id":"T18622","span":{"begin":31,"end":38},"obj":"Positive_regulation"},{"id":"T18621","span":{"begin":43,"end":53},"obj":"Gene_expression"},{"id":"T18620","span":{"begin":39,"end":42},"obj":"Protein"}],"relations":[{"id":"R12402","pred":"themeOf","subj":"T18620","obj":"T18621"},{"id":"R12403","pred":"themeOf","subj":"T18621","obj":"T18622"}],"text":"Moreover, miR-155 was shown to promote TNF production, a key process in the pathogenesis of RA [87]. miR-146 and miR-155 may therefore be important negative regulators of inflammation in RA and their potential for the development of new treatments is substantial."}

{"project":"test3","denotations":[{"id":"T17417","span":{"begin":113,"end":120},"obj":"Protein"},{"id":"T17416","span":{"begin":43,"end":53},"obj":"Gene_expression"},{"id":"T17415","span":{"begin":39,"end":42},"obj":"Protein"},{"id":"T17414","span":{"begin":31,"end":38},"obj":"Positive_regulation"},{"id":"T17413","span":{"begin":10,"end":17},"obj":"Protein"},{"id":"T17382","span":{"begin":113,"end":120},"obj":"Protein"},{"id":"T17381","span":{"begin":39,"end":42},"obj":"Protein"},{"id":"T17380","span":{"begin":10,"end":17},"obj":"Protein"}],"relations":[{"id":"R11393","pred":"causeOf","subj":"T17413","obj":"T17414"},{"id":"R11394","pred":"themeOf","subj":"T17415","obj":"T17416"},{"id":"R11395","pred":"themeOf","subj":"T17416","obj":"T17414"}],"text":"Moreover, miR-155 was shown to promote TNF production, a key process in the pathogenesis of RA [87]. miR-146 and miR-155 may therefore be important negative regulators of inflammation in RA and their potential for the development of new treatments is substantial."}